271 related articles for article (PubMed ID: 34652632)
41. X-linked adrenoleukodystrophy (X-ALD): clinical presentation and guidelines for diagnosis, follow-up and management.
Engelen M; Kemp S; de Visser M; van Geel BM; Wanders RJ; Aubourg P; Poll-The BT
Orphanet J Rare Dis; 2012 Aug; 7():51. PubMed ID: 22889154
[TBL] [Abstract][Full Text] [Related]
42. Case report of dysregulation of primary bile acid synthesis in a family with X-linked adrenoleukodystrophy.
Płatek T; Orso E; Zapała B; Polus A; Kieć-Wilk B; Piwowar M; Chojnacka M; Ciałowicz U; Malczewska-Malec M; Schmitz G; Solnica B; Dembińska-Kieć A
Medicine (Baltimore); 2018 Dec; 97(49):e13353. PubMed ID: 30544401
[TBL] [Abstract][Full Text] [Related]
43. ABCD1 and X-linked adrenoleukodystrophy: A disease with a markedly variable phenotype showing conserved neurobiology in animal models.
Manor J; Chung H; Bhagwat PK; Wangler MF
J Neurosci Res; 2021 Dec; 99(12):3170-3181. PubMed ID: 34716609
[TBL] [Abstract][Full Text] [Related]
44. X-linked adrenoleukodystrophy is a frequent cause of idiopathic Addison's disease in young adult male patients.
Laureti S; Casucci G; Santeusanio F; Angeletti G; Aubourg P; Brunetti P
J Clin Endocrinol Metab; 1996 Feb; 81(2):470-4. PubMed ID: 8636252
[TBL] [Abstract][Full Text] [Related]
45. Molecular Biomarkers for Adrenoleukodystrophy: An Unmet Need.
Honey MIJ; Jaspers YRJ; Engelen M; Kemp S; Huffnagel IC
Cells; 2021 Dec; 10(12):. PubMed ID: 34943935
[TBL] [Abstract][Full Text] [Related]
46. [X-linked adrenoleukodystrophy in a female proband: clinical presentation, biological diagnosis and family consequences].
Lesca G; Vanier MT; Creisson E; Bendelac N; Hainque B; Ollagnon-Roman E; Aubourg P
Arch Pediatr; 2005 Aug; 12(8):1237-40. PubMed ID: 15878823
[TBL] [Abstract][Full Text] [Related]
47. Investigating ABCD1 mutations in a Taiwanese cohort with hereditary spastic paraplegia phenotype.
Hsu SL; Chen YH; Chou CT; Chou YT; Tsai YS; Hsiao CT; Liao YC; Lee YC
Parkinsonism Relat Disord; 2021 Nov; 92():7-12. PubMed ID: 34649108
[TBL] [Abstract][Full Text] [Related]
48. [X-linked adrenoleukodystrophy: A case of acute childhood cerebral presentation].
Posada Bustos S; Charry Lopez ML; Espinosa García E
Andes Pediatr; 2021 Aug; 92(4):602-608. PubMed ID: 34652380
[TBL] [Abstract][Full Text] [Related]
49. Putative X-linked adrenoleukodystrophy gene shares unexpected homology with ABC transporters.
Mosser J; Douar AM; Sarde CO; Kioschis P; Feil R; Moser H; Poustka AM; Mandel JL; Aubourg P
Nature; 1993 Feb; 361(6414):726-30. PubMed ID: 8441467
[TBL] [Abstract][Full Text] [Related]
50. Identification of Two Novel Mutations of
Dong B; Lv W; Xu L; Zhao Y; Sun X; Wang Z; Cheng B; Fu Z; Wang Y
Int J Endocrinol; 2022; 2022():5479781. PubMed ID: 35479665
[TBL] [Abstract][Full Text] [Related]
51. Pathomechanisms underlying X-adrenoleukodystrophy: a three-hit hypothesis.
Singh I; Pujol A
Brain Pathol; 2010 Jul; 20(4):838-44. PubMed ID: 20626745
[TBL] [Abstract][Full Text] [Related]
52. Adrenoleukodystrophy - neuroendocrine pathogenesis and redefinition of natural history.
Kemp S; Huffnagel IC; Linthorst GE; Wanders RJ; Engelen M
Nat Rev Endocrinol; 2016 Oct; 12(10):606-15. PubMed ID: 27312864
[TBL] [Abstract][Full Text] [Related]
53. Defining diagnostic cutoffs in neurological patients for serum very long chain fatty acids (VLCFA) in genetically confirmed X-Adrenoleukodystrophy.
Rattay TW; Rautenberg M; Söhn AS; Hengel H; Traschütz A; Röben B; Hayer SN; Schüle R; Wiethoff S; Zeltner L; Haack TB; Cegan A; Schöls L; Schleicher E; Peter A
Sci Rep; 2020 Sep; 10(1):15093. PubMed ID: 32934269
[TBL] [Abstract][Full Text] [Related]
54. Novel ABCD1 variant causes phenotype of adrenomyeloneuropathy with cerebral involvement in Ukrainian siblings: first adult hematopoietic stem cell transplantation for ALD in Ukraine: a case report.
Shchubelka K; Herasymenko O; Budzyn A; Lysytsia O; Rusyn A; Oleksyk O; Tynta S; Oleksyk T
J Med Case Rep; 2024 Jan; 18(1):25. PubMed ID: 38245786
[TBL] [Abstract][Full Text] [Related]
55. Impaired very long-chain acyl-CoA β-oxidation in human X-linked adrenoleukodystrophy fibroblasts is a direct consequence of ABCD1 transporter dysfunction.
Wiesinger C; Kunze M; Regelsberger G; Forss-Petter S; Berger J
J Biol Chem; 2013 Jun; 288(26):19269-79. PubMed ID: 23671276
[TBL] [Abstract][Full Text] [Related]
56. X-linked Adrenoleukodystrophy in a 20-Year-Old Male With an ABCD1 Gene Mutation: First Case From Pakistan.
Ghori M; Molani RA; Ibrahim PMN; Hanif MI; Jamal Raza J
Cureus; 2022 Feb; 14(2):e21837. PubMed ID: 35291541
[TBL] [Abstract][Full Text] [Related]
57. ABCD1 translation-initiator mutation demonstrates genotype-phenotype correlation for AMN.
O'Neill GN; Aoki M; Brown RH
Neurology; 2001 Dec; 57(11):1956-62. PubMed ID: 11739809
[TBL] [Abstract][Full Text] [Related]
58. Molecular characterization of X-linked adrenoleukodystrophy in a Tunisian family: identification of a novel missense mutation in the ABCD1 gene.
Kallabi F; Hadj Salem I; Ben Salah G; Ben Turkia H; Ben Chehida A; Tebib N; Fakhfakh F; Kamoun H
Neurodegener Dis; 2013; 12(4):207-11. PubMed ID: 23651979
[TBL] [Abstract][Full Text] [Related]
59. Metformin-induced mitochondrial function and ABCD2 up-regulation in X-linked adrenoleukodystrophy involves AMP-activated protein kinase.
Singh J; Olle B; Suhail H; Felicella MM; Giri S
J Neurochem; 2016 Jul; 138(1):86-100. PubMed ID: 26849413
[TBL] [Abstract][Full Text] [Related]
60. Novel ABCD1 gene mutations in Iranian pedigrees with X-linked adrenoleukodystrophy.
Emamalizadeh B; Daneshmandpour Y; Tafakhori A; Ranji-Burachaloo S; Shafiee S; Ghods E; Darvish H
J Pediatr Endocrinol Metab; 2019 Nov; 32(11):1207-1215. PubMed ID: 31665121
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
